Form 8-K - Current report:
SEC Accession No. 0000950170-24-135031
Filing Date
2024-12-10
Accepted
2024-12-10 17:00:09
Documents
11
Period of Report
2024-12-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K aplt-20241206.htm   iXBRL 8-K 42541
  Complete submission text file 0000950170-24-135031.txt   160761

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT aplt-20241206.xsd EX-101.SCH 27529
13 EXTRACTED XBRL INSTANCE DOCUMENT aplt-20241206_htm.xml XML 5041
Mailing Address 545 FIFTH AVENUE, SUITE 1400 NEW YORK NY 10017
Business Address 545 FIFTH AVENUE, SUITE 1400 NEW YORK NY 10017 212-220-9226
Applied Therapeutics, Inc. (Filer) CIK: 0001697532 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38898 | Film No.: 241539238
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)